Securus Medical Group nets $6.5 mln in Series B financing
Securus Medical Group has raised $6.5 million in Series B financing. New investor 3X5 Special Opportunity Fund led the round with participation from RiverVest Venture Partners and the University of Michigan Investment in New Technology Startups program. In addition to the funding, the company has named Dr. Steven Girouard as president and CEO. Also, Nicholas Walrod, a principal at 3X5 Special Opportunity Fund, joins the company's board of directors. Based in Cleveland, Securus is a medical device company.
29 October 2013•2 mins read
